Valacyclovir HCl (Valtrex™): An Acyclovir Prodrug with Improved Pharmacokinetics and Better Efficacy for Treatment of Zoster
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 394, 33-39
- https://doi.org/10.1007/978-1-4757-9209-6_4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus diseaseAntimicrobial Agents and Chemotherapy, 1994
- Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteersClinical Pharmacology & Therapeutics, 1993
- Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysisJournal of Medical Virology, 1993
- Therapeutic Approaches to Varicella-Zoster Virus InfectionsThe Journal of Infectious Diseases, 1992
- A 54-year-old woman with fevers, arthralgias, myalgias, and rashThe American Journal of Medicine, 1988
- Treatment of Varicella–Zoster Virus Infection in Severely Immunocompromised PatientsNew England Journal of Medicine, 1986
- Acyclovir Halts Progression of Herpes Zoster in Immunocompromised PatientsNew England Journal of Medicine, 1983
- ACYCLOVIR THERAPY FOR ACUTE HERPES ZOSTERThe Lancet, 1982
- ACYCLOVIR IN HERPES ZOSTERThe Lancet, 1981
- THE NATURAL HISTORY OF HERPES ZOSTERJAMA, 1957